ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company employs 6 full-time employees The company went IPO on 2000-03-13. The company has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The firm is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.
ALRTF stock price ended at $0.02 on 星期二, after rising 0.00%
On the latest trading day Jan 20, 2026, the stock price of ALRTF rose by 0.00%, climbing from $0.02 to $0.02. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.02 and a high of $0.02. Notably, trading volume dropped by 88.9K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 104.2K shares were traded, equating to a market value of approximately $12.7M.